15 completed, 7 terminated, 1 recruiting, 1 unknown. 25 Phase 2, 8 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Completed 15, Terminated 7, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 8 | Completed 5, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Terminated 1, Unknown 1 |
Follow Quetiapine: new trials by email Literature Review of Quetiapine trials Research Report on Quetiapine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia | Phase 2 / Phase 3 | Recruiting | Lone Baandrup | 255 | 2023-09-18 | 2025-04-24 |
| Quetiapine in Prevention of Delirium Quetiapine - Delirium | Phase 2 | Completed | Ain Shams University | 90 | 2023-03-01 | 2023-07-10 |
| A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression BI 1358894, Placebo, Quetiapine - Depressive Disorder, Major | Phase 2 | Completed | Boehringer Ingelheim | 389 | 2020-11-20 | 2025-03-06 |
| Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine Pimavanserin, Placebo, Quetiapine - Parkinson's Disease | Phase 2 | Terminated | ACADIA Pharmaceuticals Inc. | 11 | 2019-10-23 | 2021-10-14 |
| Quetiapine Treatment for Pediatric Delirium Quetiapine, Placebo - Delirium | Phase 2 / Phase 3 | Withdrawn | Medical College of Wisconsin | 2019-04-15 | 2020-04-08 | |
| A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication ASP4345, placebo, risperidone - Schizophrenia | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 233 | 2018-07-13 | 2024-11-12 |
| A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry Aripiprazole, Olanzapine, Paliperidone - Schizophrenia, Schizoaffective Disorder | Phase 2 | Terminated | Janssen Research & Development, LLC | 9 | 2015-05-01 | 2017-03-29 |
| Efficacy of Quetiapine for Pediatric Delirium quetiapine, Placebo - Delirium | Phase 1 / Phase 2 | Terminated | Weill Medical College of Cornell University | 6 | 2015-03-01 | 2017-12-13 |
| The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment Risperidone, Olanzapine, Quetiapine - Schizophrenia | Phase 1 / Phase 2 | Unknown | Shanxi Medical University | 200 | 2013-01-01 | 2016-01-08 |
| Quetiapine Pharmacotherapy for Cannabis Dependence Quetiapine, Placebo - Cannabis Dependence | Phase 2 | Completed | New York State Psychiatric Institute | 130 | 2012-10-01 | 2019-03-05 |
| A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes FK949E, Placebo - Bipolar Disorder | Phase 2 / Phase 3 | Completed | Astellas Pharma Inc | 431 | 2012-02-07 | 2024-11-15 |
| A Long-Term, Open-Label, Study on Schizophrenia LY2140023, Olanzapine, Aripiprazole - Schizophrenia | Phase 2 / Phase 3 | Terminated | Denovo Biopharma LLC | 560 | 2010-06-01 | 2026-09-14 |
| Study of Quetiapine Treatment for Cannabis Dependence quetiapine - Cannabis Dependence | Phase 2 | Completed | New York State Psychiatric Institute | 15 | 2009-08-01 | 2019-04-24 |
| Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression Lu AA39959, Placebo, Quetiapine - Bipolar Disorder | Phase 2 | Terminated | H. Lundbeck A/S | 105 | 2008-12-01 | 2014-05-28 |
| Effect of Quetiapine on Marijuana Withdrawal and Relapse Marijuana, Quetiapine, Placebo oral capsule - Marijuana Smoking | Phase 2 | Completed | New York State Psychiatric Institute | 20 | 2008-08-01 | 2017-08-18 |
| Seroquel for Frequent, Heavy Drinkers Seroquel, Placebo - Alcoholism | Phase 2 | Completed | University of Pennsylvania | 156 | 2008-01-01 | 2014-09-17 |
| Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study Seroquel® - Alcohol Relapse Prevention, Alcoholism | Phase 2 | Completed | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 40 | 2007-11-01 | 2011-04-18 |
| Quetiapine in Postpartum Depression Quetiapine - Postpartum Depressive Disorder | Phase 2 | Terminated | AstraZeneca | 5 | 2007-08-01 | 2010-12-21 |
| Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders Quetiapine, Cogntive behavioral therapy - Insomnia | Phase 2 / Phase 3 | Completed | Michael E. DeBakey VA Medical Center | 32 | 2007-04-01 | 2013-04-23 |
| A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study quetiapine - Anorexia Nervosa | Phase 2 | Terminated | University of South Florida | 24 | 2007-02-01 | 2012-06-18 |
Showing 20 of 25. Sign in to see all of them.
Schizophrenia (5) · Bipolar Disorder (3) · Delirium (3) · Depression (3) · Alcoholism (2) · Marijuana Abuse (2) · Psychotic Disorders (2) · Sleep Initiation and Maintenance Disorders (2) · Alcohol Drinking (1) · Anorexia (1) · Anorexia Nervosa (1) · Attention Deficit Disorder with Hyperactivity (1) · Depression, Postpartum (1) · Depressive Disorder, Major (1) · Disease (1)
New York State Psychiatric Institute (3) · AstraZeneca (2) · ACADIA Pharmaceuticals Inc. (1) · Ain Shams University (1) · Astellas Pharma Global Development, Inc. (1) · Astellas Pharma Inc (1) · Boehringer Ingelheim (1) · Denovo Biopharma LLC (1) · Duke University (1) · H. Lundbeck A/S (1) · Indiana University (1) · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH (1) · Janssen Research & Development, LLC (1) · Lone Baandrup (1) · Manhattan Psychiatric Center (1)
United States (18) · Germany (3) · Japan (3) · Russia (2) · Argentina (1) · Australia (1) · Bulgaria (1) · Canada (1) · China (1) · Croatia (1) · Czechia (1) · Denmark (1) · Egypt (1) · France (1) · Hungary (1)
John J Mariani, MD (2) · Bernhard Croissant, MD PhD (1) · Chani Traube, MD (1) · David Dunn, MD (1) · Holly Swartz, M.D. (1) · Jean-Pierre Lindenmayer, MD (1) · Jonathan Davidson, M.D. (1) · Karl Mann, MD PhD (1) · Kyle M Kampman, M.D. (1) · Leslie Citrome, MD (1)
PMID 21346616, PMID 22420597, PMID 22741619, PMID 31242884, PMID 32518042, PMID 32533536, PMID 32792252, PMID 40900110
2019 (1), 2023 (1), K23DA021209 (1), P50DA009236 (1), R01DA031826 (1)